OCUL logo

OCUL
Ocular Therapeutix Inc

10,622
Mkt Cap
$2.65B
Volume
2.69M
52W High
$13.85
52W Low
$5.79
PE Ratio
-8.76
OCUL Fundamentals
Price
$14.00
Prev Close
$12.43
Open
$12.49
50D MA
$11.64
Beta
1.58
Avg. Volume
2.49M
EPS (Annual)
-$1.22
P/B
8.52
Rev/Employee
$232,565.69
Loading...
Loading...
News
all
press releases
Ocular Therapeutix (NASDAQ:OCUL) Trading Up 12.3% - What's Next?
Ocular Therapeutix (NASDAQ:OCUL) Shares Up 12.3% - Here's What Happened...
MarketBeat·8h ago
News Placeholder
More News
News Placeholder
Intech Investment Management LLC Sells 22,361 Shares of Ocular Therapeutix, Inc. $OCUL
Intech Investment Management LLC lessened its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 19.7% during the second quarter, according to the company in its most recent 13F...
MarketBeat·9d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Earns "Buy" Rating from HC Wainwright
HC Wainwright restated a "buy" rating and issued a $19.00 price target on shares of Ocular Therapeutix in a research report on Tuesday...
MarketBeat·10d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded shares of Ocular Therapeutix from a "sell" rating to a "hold" rating in a research report on Monday...
MarketBeat·12d ago
News Placeholder
Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet
The consensus price target hints at an 82.5% upside potential for Ocular Therapeutix (OCUL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·15d ago
News Placeholder
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) have received a consensus rating of "Moderate Buy" from the fourteen analysts that are covering the stock, MarketBeat.com reports...
MarketBeat·16d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen lowered Ocular Therapeutix from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·20d ago
News Placeholder
Chardan Capital Issues Optimistic Forecast for OCUL Earnings
Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) - Stock analysts at Chardan Capital lifted their FY2025 earnings estimates for Ocular Therapeutix in a note issued to investors on Wednesday...
MarketBeat·26d ago
News Placeholder
Y Intercept Hong Kong Ltd Buys New Holdings in Ocular Therapeutix, Inc. $OCUL
Y Intercept Hong Kong Ltd purchased a new position in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) in the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·27d ago
News Placeholder
HC Wainwright Cuts Earnings Estimates for Ocular Therapeutix
Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) - Equities research analysts at HC Wainwright reduced their Q4 2025 earnings per share (EPS) estimates for Ocular Therapeutix in a report issued...
MarketBeat·28d ago

Latest OCUL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.